We Update you with the Clock Running. Health Care News, Disease, Diagnose, Physicians, Residents, Medical Officers, Nursing Care, Technical Staff, Health Policies, Organizations, Certification, Standards, Alerts, and All about Worlds Health. Step to Facilitate the Health Care Professionals and Patients. Provide Safety and Quality to Patient's, Health Care staff, Explains Patient Family Education and Rights.
Hollis-Eden Pharmaceuticals Commences Phase I/II Clinical Trial In Ulcerative Colitis With Novel Oral Anti-Inflammatory Drug Candidate TRIOLEX(TM)
Clinical Trials / Drug Trials Hollis-Eden Pharmaceuticals, Inc. (NASDAQ:HEPH), the world leader in the development of a new class of small molecule compounds based on endogenous steroid hormones, announced that it has commenced a Phase I/II clinical trial with its oral drug candidate TRIOLEX? (HE3286) in ulcerative colitis (UC) under an Investigational New Drug application (IND) cleared by the U.S. Food and Drug Administration (FDA) for this indication.
